Iluvien TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: fluocinolone
Pack: Iluvien 190 microgram implant, 1, applicator
Brand name
(ARTG)
: ILUVIEN fluocinolone acetonide 190 mcg intravitreal implant in applicatorDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
ILUVIEN is indicated for the treatment of diabetic macular oedema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Implant
- Intravitreal-Within The Vitreous Cavity Of The Eye
- Drug core is a light brown filled tube, no visible deformation
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Do not Refrigerate
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 implant in applicator pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient fluocinolone
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
